OpenURL Connection Search

Select item for more details and to access through your institution.

Complement activation in patients with sepsis is in part mediated by C-reactive protein.
Published in:
1998
By:
- Wolbink, Gert-Jan;
- Bossink, Ailko W. J.;
- Groeneveld, A. B. Johan;
- Groot, Marcel C. M. de;
- Thijs, Lambertus G.;
- Hack, C. Erik;
- Wolbink, G J;
- Bossink, A W;
- Groeneveld, A B;
- de Groot, M C;
- Thijs, L G;
- Hack, C E
Publication type:
journal article
Common variants at CD40 and other loci confer risk of rheumatoid arthritis.
Published in:
Nature Genetics, 2008, v. 40, n. 10, p. 1216, doi. 10.1038/ng.233
By:
- Raychaudhuri, Soumya;
- Remmers, Elaine F.;
- Lee, Annette T.;
- Hackett, Rachel;
- Guiducci, Candace;
- Burtt, Noël P.;
- Gianniny, Lauren;
- Korman, Benjamin D.;
- Padyukov, Leonid;
- Kurreeman, Fina A. S.;
- Chang, Monica;
- Catanese, Joseph J.;
- Bo Ding;
- Wong, Sandra;
- van der Helm-van Mil, Annette H. M.;
- Neale, Benjamin M.;
- Coblyn, Jonathan;
- Jing Cui;
- Tak, Paul P.;
- Wolbink, Gert Jan
Publication type:
Article
A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study.
Published in:
Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 23, p. 7367, doi. 10.1007/s00216-013-7154-0
By:
- Corstjens, Paul;
- Fidder, Herma;
- Wiesmeijer, Karien;
- Dood, Claudia;
- Rispens, Theo;
- Wolbink, Gert-Jan;
- Hommes, Daniel;
- Tanke, Hans
Publication type:
Article
Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped.
Published in:
Multiple Sclerosis Journal, 2012, v. 18, n. 6, p. 899, doi. 10.1177/1352458511431073
By:
- Rispens, Theo;
- Vennegoor, Anke;
- Wolbink, Gert Jan;
- Polman, Chris H;
- Killestein, Joep
Publication type:
Article
The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis.
Published in:
British Journal of Clinical Pharmacology, 2013, v. 76, n. 6, p. 939, doi. 10.1111/bcp.12142
By:
- Bemt, Bart J. F.;
- Broeder, Alfons A.;
- Wolbink, Gert‐Jan;
- Maas, Aatke;
- Hekster, Yechiel A.;
- Riel, Piet L. C. M.;
- Benraad, H. Bart;
- Hoogen, Frank H. J.
Publication type:
Article
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.
Published in:
Nature Communications, 2015, v. 6, n. 5, p. 6681, doi. 10.1038/ncomms7681
By:
- van Heemst, Jurgen;
- Jansen, Diahann T. S. L.;
- Polydorides, Savvas;
- Moustakas, Antonis K.;
- Bax, Marieke;
- Feitsma, Anouk L.;
- Bontrop-Elferink, Diënne G.;
- Baarse, Martine;
- van der Woude, Diane;
- Wolbink, Gert-Jan;
- Rispens, Theo;
- Koning, Frits;
- de Vries, René R. P.;
- Papadopoulos, George K.;
- Archontis, Georgios;
- Huizinga, Tom W.;
- Toes, René E.
Publication type:
Article
Detection of soluble human granzyme K in vitro and in vivo.
Published in:
European Journal of Immunology, 2005, v. 35, n. 10, p. 2940, doi. 10.1002/eji.200526249
By:
- Bade, Britta;
- Lohrmann, Jens;
- ten Brinke, Anja;
- Wolbink, Angela M.;
- Wolbink, Gert-Jan;
- Berge, Ineke J. M. ten;
- Virchow, J. Christian;
- Luttmann, Werner;
- Hack, C. Erik
Publication type:
Article

Found: 7

Complement activation in patients with sepsis is in part mediated by C-reactive protein.

Common variants at CD40 and other loci confer risk of rheumatoid arthritis.

A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study.

Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped.

The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis.

Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.

Detection of soluble human granzyme K in vitro and in vivo.